Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
BABA Alibaba Group Holding Ltd
OBMP OncBioMune Pharmaceuticals Inc
AVNW Aviat Networks Inc
AMPY Amplify Energy Corp
JEPI JPMorgan Equity Premium Income ETF
VOLAF Volvo AB
AGNC Agnc Investment Corp
GME GameStop Corp
HMNKF HMS Networks AB
Go

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).

Closing Price
$107.91
Day's Change
1.02 (0.95%)
Bid
--
Ask
--
B/A Size
--
Day's High
108.55
Day's Low
107.14
Volume
(Above Average)
Volume:
8,207,672

10-day average volume:
7,055,703
8,207,672

Norwegian Cruise CEO's total pay more than doubles to over $36 million during year of COVID

1:26 pm ET April 7, 2021 (MarketWatch)
Print

Tomi Kilgore

CEO Del Rio's base salary was reduced by about $272,500 amid the pandemic, but he got a $2.8 million 'inducement' bonus to stay with the company through 2021

In a year in which Norwegian Cruise Line Holdings Ltd. lost $4 billion and employee salaries were cut by 20% as the cruise operator struggled to deal COVID-19-related shutdowns, Chief Executive Frank Del Rio's total pay more than doubled to over $36 million.

The company (NCLH) disclosed Wednesday in its proxy statement filed with the Securities and Exchange Commission (https://www.sec.gov/Archives/edgar/data/1513761/000110465921047349/tm217574-4_def14a.htm) that Del Rio's total compensation in 2020 was $36.38 million, up from $17.81 million in 2019.

The biggest part of the increase was "all other compensation," which rose to $10.48 million from $270,040.

Included in that increase was $10.27 million from a "prior contract payout," which was owed under his previous employment agreement that was amended in August 2017, the filing showed.

Also included was a $100,000 "travel expense allowance," $20,000 for "country club membership" and a $12,000 "personal allowance," all the same as the year before. Meanwhile, the 401(k) match increased to $14,025 in 2020 from $13,700 in 2019.

Keep in mind that the "COVID-19 Action Plan (https://www.nclhltdinvestor.com/news-releases/news-release-details/norwegian-cruise-line-holdings-ltd-provides-business-update)" announced a year ago in the early stages of the pandemic included "suspended travel for shoreside employees across the organization" and "paused employer 401(k) match contribution."

The action plan also included 20% salary reduction for shoreside employees, which when prorated led to Del Rio's base salary being cut by $272,459, or 15%, to $1.53 million.

Instead, Del Rio received a $2.82 million "inducement bonus" in 2020, after not receiving any bonus the prior two years, that required Del Rio to stay with the company through 2021. If Del Rio leaves the company for any reason other than a qualifying termination, he would be required to repay 100% of the inducement bonus.

Elsewhere in Del Rio's 2020 pay package, non-equity incentive plan compensation was unchanged at $3.60 million, while the value of stock awards increased to $17.95 million from $12.20 million in 2019.

Meanwhile, Del Rio said in February that 2020 was "without a doubt the most challenging year in the company's 50 plus year history," as the company swung to a net loss of $4.01 billion from net income of $930.2 million in 2019 and as total revenue dropped 80.2% to $1.28 billion.

Norwegian Cruise's stock rallied 1.2% in afternoon trading Wednesday, putting it on track for a sixth straight gain. The stock has climbed 23.7% year to date.

The stock has been rallying recently as investors saw the light at the end of a long tunnel. Norwegian Cruise said this week it was planning to restart cruise operations (https://www.marketwatch.com/story/norwegian-cruise-unveils-phased-approach-for-return-of-cruises-starting-in-july-2021-04-06) from U.S. ports on July 4, following its request (https://www.marketwatch.com/story/norwegian-cruise-stock-surges-after-plan-submitted-to-cdc-to-resume-us-cruises-in-july-2021-04-05) that the Centers for Disease Control and Prevention (CDC) lift its Conditional Sail Order (https://www.cdc.gov/media/releases/2021/s0402-conditional-sail-orders.html).

In 2020, the stock plunged 56.5%, after surging 37.8% in 2019. In comparison, shares of rivals Royal Caribbean Group (RCL) fell 44.1% in 2020 and Carnival Corp. (CCL) stock dropped 57.4%, while the S&P 500 index gained 16.3%.

Among Norwegian Cruise's other named executive officers (NEOs), total compensation in 2020 for Chief Financial Officer Mark Kempa increased 44.7% from 2019 to $5.79 million; for Executive Vice President, Vessel Operations Robin Lindsay rose 71.3% to $6.85 million; for Chief Executive Officer, Regent Jason Montague grew 58.7% to $6.36 million; and for CEO, Norwegian Harry Sommer rose 57.0% to $6.29 million.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

	

(END) Dow Jones Newswires

April 07, 2021 13:26 ET (17:26 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.